Facebook Twitter LinkedIn Google Plus RSS

FDA delays ruling on expanded use of fish-oil pill from Bedminster drugmaker Source: The Star-Ledger

Federal regulators have delayed ruling on a Bedminster-based pharmaceutical company's application to expand the use of a fish-oil pill to include cardiovascular benefits, Bloomberg reported.

Continue Reading »»

You May Have Missed...

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close